Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer

American Journal of Surgery

Volumn 210, Issue 3, 2015, Pages 526-535

  Zhang, Hua ^a   Xia, Honggang ^b   Zhang, Lianmin ^a   Zhang, Bin ^a   Yue, Dongsheng ^a   Wang, Changli ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Haibin People's Hospital   (China)

Author keywords

Neutrophil lymphocyte ratio; Non small cell lung cancer; Platelet lymphocyte ratio; Prognosis

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER PROGNOSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; AGED; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL; PREOPERATIVE PERIOD; PROGNOSIS; THROMBOCYTE COUNT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; PLATELET COUNT; PNEUMONECTOMY; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84945985736     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2015.03.022     Document Type: Article

References (38)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. M.M. Moore, W. Chua, K.A. Charles, and et al. Inflammation and cancer: causes and consequences Clin Pharmacol Ther 87 2010 504 508
3. C. O'Dowd, L.A. McRae, D.C. McMillan, and et al. Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer J Thorac Oncol 5 2010 988 992
4. D.W. Yuan, K. Zhu, K. Li, and et al. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction J Surg Oncol 110 2014 333 340
5. H.C. Kwon, S.H. Kim, S.Y. Oh, and et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer Biomarkers 17 2012 216 222
6. V. Asher, J. Lee, A. Innamaa, and et al. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer Clin Transl Oncol 13 2011 499 503
7. R.A. Smith, L. Bosonnet, M. Raraty, and et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma Am J Surg 197 2009 466 472
8. B. Azab, N. Shah, J. Radbel, and et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients Med Oncol 30 2013 432
9. I. Bhatti, O. Peacock, G. Lloyd, and et al. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio Am J Surg 200 2010 197 203
10. T. Kacan, N.A. Babacan, M. Seker, and et al. Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? Asian Pac J Cancer Prev 15 2014 2089 2094
11. D. Unal, C. Eroglu, N. Kurtul, and et al. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev 14 2013 5237 5242
12. M. Yildirim, M. Yildiz, E. Duman, and et al. Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer J BUON 18 2013 728 732
13. Y. Yao, D. Yuan, H. Liu, and et al. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy Cancer Immunol Immunother 62 2013 471 479
14. S. Cedrés, D. Torrejon, A. Martínez, and et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer Clin Transl Oncol 14 2012 864 869
15. K.M. Sarraf, E. Belcher, E. Raevsky, and et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 425 428
16. M. Tomita, T. Shimizu, T. Ayabe, and et al. Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer Anticancer Res 31 2011 2995 2998
17. D.J. Pinato, R.J. Shiner, M.J. Seckl, and et al. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer Br J Cancer 110 2014 1930 1935
18. K. Sánchez-Lara, J.G. Turcott, E. Juárez, and et al. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study Nutr Cancer 64 2012 526 534
19. H. Liu, Y. Wu, Z. Wang, and et al. Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer J Thorac Dis 5 2013 783 789
20. O. Arrieta, R.M. Michel Ortega, G. Villanueva-Rodríguez, and et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study BMC Cancer 10 2010 50
21. L.M. Forrest, D.C. McMillan, C.S. McArdle, and et al. A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer Br J Cancer 92 2005 1834 1836
22. Z. Giannousi, I. Gioulbasanis, A.G. Pallis, and et al. Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis Support Care Cancer 20 2012 1823 1829
23. G. Garcea, N. Ladwa, C.P. Neal, and et al. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma World J Surg 35 2011 868 872
24. E. Brambilla, W.D. Travis, T.V. Colby, and et al. The new World Health Organization classification of lung tumors Eur Respir J 18 2001 1059 1068
25. F.C. Detterbeck, D.J. Boffa, and L.T. Tanoue The new lung cancer staging system Chest 136 2009 260 272
26. F. Colotta, P. Allavena, A. Sica, and et al. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability Carcinogenesis 30 2009 1073 1081
27. M.L. Batista Jr., M. Olivan, P.S. Alcantara, and et al. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients Cytokine 61 2013 532 539
28. D.H. Esper, and W.A. Harb The cancer cachexia syndrome: a review of metabolic and clinical manifestations Nutr Clin Pract 20 2005 369 376
29. F. Balkwill, and A. Mantovani Inflammation and cancer: Back to Virchow? Lancet 357 2001 539 545
30. E. Elkord, E.M. Alcantar-Orozco, S.J. Dovedi, and et al. T regulatory cells in cancer: recent advances and therapeutic potential Expert Opin Biol Ther 10 2010 1573 1586
31. A. Mantovani, P. Allavena, A. Sica, and et al. Cancer-related inflammation Nature 454 2008 436 444
32. Y.K. Vashist, J. Loos, J. Dedow, and et al. Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer Ann Surg Oncol 18 2011 1130 1138
33. H.W. Bruckner, P.T. Lavin, S.C. Plaxe, and et al. Absolute granulocyte, lymphocyte, and monocyte counts JAMA 247 1982 1004 1006
34. M. Ikeda, H. Furukawa, H. Imamura, and et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer Ann Surg Oncol 9 2002 287 291
35. Y. Mohri, K. Tanaka, M. Ohi, and et al. Prognostic significance of host- and tumor-related factors in patients with gastric Cancer World J Surg 34 2010 285 290
36. T. Yamanaka, S. Matsumoto, S. Teramukai, and et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer Oncology 73 2007 215 220
37. X. An, P.R. Ding, F.H. Wang, and et al. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma Tumour Biol 32 2011 317 324
38. H. Shimada, N. Takiguchi, O. Kainuma, and et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer Gastric Cancer 13 2010 170 176